Cargando…
Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis
MAPK and AKT pathways are frequently co-activated in melanoma through overexpression of receptor tyrosine kinases, mutations in their signaling surrogates, such as RAS and BRAF, or loss of negative regulators such as PTEN. Since RAS can be a positive upstream regulator of PI3-K, it has been proposed...
Autores principales: | Nogueira, Cristina, Kim, Kwan-Hyun, Sung, Hyeran, Paraiso, Kim, Dannenberg, Jan-Hermen, Bosenberg, Marcus, Chin, Lynda, Kim, Minjung |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989338/ https://www.ncbi.nlm.nih.gov/pubmed/20711233 http://dx.doi.org/10.1038/onc.2010.349 |
Ejemplares similares
-
BRaf(V600E) cooperates with Pten silencing to elicit metastatic melanoma
por: Dankort, David, et al.
Publicado: (2009) -
Decoding Melanoma Metastasis
por: Damsky, William E., et al.
Publicado: (2010) -
Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation
por: Sung, Hyeran, et al.
Publicado: (2016) -
Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten−/− melanoma
por: Scortegagna, Marzia, et al.
Publicado: (2013) -
Activated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanoma
por: Yang, H, et al.
Publicado: (2017)